Former Fred Hutch president joins board of TwinStrand Biosciences

Seattle-based biotech TwinStrand Biosciences, Inc. named former Fred Hutchinson Cancer Research Center president Dr. Gary Gilliland to its board this week, the company announced Wednesday. Gilliland, president emeritus at Fred Hutch, served as its president until stepping down last February. TwinStrand, which focuses on sequencing DNA to diagnose cancer, spun out of the University of Washington in 2015 and officially began operations in 2017. Last year, the company brought in a $1 6 million Series…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news